Skip to main content
. 2024 Jul 18;15:216. doi: 10.1186/s13287-024-03834-w

Fig. 4.

Fig. 4

Flow cytometry analyses of B cell, plasma cell, and B1 cell among splenocytes and KIIs of MRL/lpr mice after hUCMSC-EVs treatment. (a, c) Representative flow cytometry analyses images of CD19+CD3 (B cell) and CD45+CD3CD19CD138+ (plasma cell) among splenocytes. (b, d, e) Percentages of B cell, plasma cell, and B1 cell among splenocytes of normal mice or MRL/lpr mice treated by PBS, hUCMSCs or hUCMSC-EVs. (f, g, h) The frequency of B cell, plasma cell, and B1 cell among KIIs of MRL/lpr mice treated by PBS, hUCMSCs, or hUCMSC-EVs. Data are expressed as mean ± SD, *p < 0.05, **p < 0.01, *** p < 0.001 vs. the PBS group